| AUC | Area Under the Curve |
| Arg | Arginase |
| Arg-1 | Arginase-1 |
| Arg-2 | Arginase-2 |
| ARGACT | Arginase Activity |
| ASRM | American Society for Reproductive Medicine |
| BRCA2 | Breast Cancer 2, a gene associated with increased risk of breast cancer |
| CI | Confidence Interval |
| DE | Deep Endometriosis |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| GB | Group B (Patients with endometriosis) |
| GK1 | Group K1 (Control Group 1) |
| GK2 | Group K2 (Control Group 2) |
| HLA | Human Leukocyte Antigen |
| IFN-γ | Interferon-Gamma |
| IL-2 | Interleukin-2 |
| IL-6 | Interleukin-6 |
| K1 | Control Group 1 |
| K2 | Control Group 2 |
| MCP-1 | Monocyte Chemoattractant Protein-1 |
| MDSCs | Myeloid-Derived Suppressor Cells |
| MIF | Macrophage Migration Inhibitory Factor |
| miR-199a | MicroRNA-199a |
| miR-542-3p | MicroRNA-542-3p |
| MRI | Magnetic Resonance Imaging |
| NOS | Nitric Oxide Synthase |
| NO | Nitric Oxide |
| NK | Natural Killer |
| PON-1 | Paraoxonase-1 |
| rASRM | Revised American Society for Reproductive Medicine |
| ROC | Receiver Operating Characteristic |
| ROS | Reactive Oxygen Species |
| SM | Sclerosis Multiplex |
| SnOUT | Sensitivity to rule OUT |
| SpIN | Specificity to rule IN |
| TCR | T-cell Receptor |
| TNFα | Tumour Necrosis Factor-alpha |
| TVUS | Transvaginal Ultrasound |
| USG | Ultrasonography |